Real-time enrollment status for this metastatic castration resistant prostate cancer (mcrpc) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:02 AM UTC
| NCT Number | NCT03460977 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration Resistant Prostate Cancer (mCRPC) |
| Phase | Clinical Trial |
| Target Enrollment | 453 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | July 9, 2026 (4 days ago) |
As of July 13, 2026: Clinical trial NCT03460977 is currently recruiting participants. This clinical trial study for metastatic castration resistant prostate cancer (mcrpc) is actively seeking new participants at 46 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03460977 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03460977 was last updated 4 days ago (July 9, 2026). HelloStudys verifies this status automatically.